Imepitoin

Imepitoin is an anticonvulsant medication primarily used in veterinary medicine to manage epilepsy in dogs. It is a partial agonist of the benzodiazepine receptor site in the brain, which makes it less likely to cause sedation and ataxia than full agonists when used at therapeutic doses.

Etymology[edit | edit source]

The term "Imepitoin" is derived from its chemical structure, which is 4,5-dihydro-6-(2-propoxyphenyl)-7H-pyrrolo[3,4-b]pyridin-7-one.

Pharmacology[edit | edit source]

Imepitoin has a unique mechanism of action. It is a partial agonist at the benzodiazepine receptor site in the brain, which means it has a lower risk of sedation and ataxia than full agonists. It also has a low potential for tolerance and dependence, which makes it a suitable long-term treatment for chronic conditions like epilepsy.

Clinical Use[edit | edit source]

Imepitoin is primarily used in veterinary medicine to manage epilepsy in dogs. It is particularly effective for dogs that have a low seizure threshold. The medication is usually well-tolerated, with the most common side effects being transient ataxia and increased appetite.

Related Terms[edit | edit source]

See Also[edit | edit source]

Imepitoin Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.